Cargando…

Risk factors for self-reported medication adherence in community-dwelling older patients with multimorbidity and polypharmacy: a multicenter cross-sectional study

BACKGROUND: Medication nonadherence is a significant public health problem as it contributes to poor clinical outcomes and increased healthcare costs. Older patients with multimorbidity and polypharmacy often have low medication adherence. These patients also have a high prevalence of potentially in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jiaming, Yu, Yongpei, Yan, Suying, Zeng, Yan, Su, Su, He, Tiantian, Wang, Zimin, Ding, Qian, Zhang, Ruixue, Li, Wenchao, Wang, Xin, Zhang, Lan, Yue, Xiaolin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900971/ https://www.ncbi.nlm.nih.gov/pubmed/36740694 http://dx.doi.org/10.1186/s12877-023-03768-7

Ejemplares similares

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
por: Zhao, Yong, et al.
Publicado: (2023)

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers
por: Goto, Toshihiko, et al.
Publicado: (2021)

Multimorbidity and polypharmacy: a risk factor for older patients
por: Cucinotta, Domenico
Publicado: (2022)

Polypharmacy in multimorbid older adults: protocol for a systematic review
por: Sirois, Caroline, et al.
Publicado: (2017)

Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review
por: Ulley, Joanna, et al.
Publicado: (2019)

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice
por: von Buedingen, Fiona, et al.
Publicado: (2018)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
por: Villén, Noemí, et al.
Publicado: (2022)

A combination of Beers and STOPP criteria better detects potentially inappropriate medications use among older hospitalized patients with chronic diseases and polypharmacy: a multicenter cross-sectional study
por: Tang, Jing, et al.
Publicado: (2023)

Nurse Practitioners’ Experiences of Polypharmacy in Community-Dwelling Older Adults
por: Pariseault, Christine, et al.
Publicado: (2020)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013
por: Lai, Shih-Wei, et al.
Publicado: (2020)

Interplay of multimorbidity and polypharmacy on a community dwelling frail elderly cohort in the peri-urban slums of Delhi, India
por: Panda, Meely, et al.
Publicado: (2020)

Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
por: Wang, Juan, et al.
Publicado: (2022)

Multimorbidity or polypharmacy: two sides of the same coin?
por: Sinnott, Carol, et al.
Publicado: (2015)

Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022)

Polypharmacy and the Change of Self-Rated Health in Community-Dwelling Older Adults
por: Barghouth, Muhammad Helmi, et al.
Publicado: (2023)

Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator
por: Assari, Shervin, et al.
Publicado: (2019)

Corrigendum: Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
por: Wang, Juan, et al.
Publicado: (2022)

Factors Associated with Medication Non-Adherence among Patients with Multimorbidity and Polypharmacy Admitted to an Intermediate Care Center
por: González-Bueno, Javier, et al.
Publicado: (2021)

Associated adverse health outcomes of polypharmacy and potentially inappropriate medications in community-dwelling older adults with diabetes
por: Lu, Lvliang, et al.
Publicado: (2023)

POLYPHARMACY, FRAILTY, AND DISABILITY-FREE SURVIVAL IN COMMUNITY-DWELLING HEALTHY OLDER INDIVIDUALS
por: Ekram, A R M Saifuddin, et al.
Publicado: (2022)

Patterns of multimorbidity and risk of disability in community-dwelling older persons
por: Marengoni, Alessandra, et al.
Publicado: (2021)

Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland
por: Zechmann, Stefan, et al.
Publicado: (2019)

Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: A retrospective cohort study
por: Jungo, Katharina Tabea, et al.
Publicado: (2022)

The evolution of an evidence based intervention designed to improve prescribing and reduce polypharmacy in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE)
por: McCarthy, Caroline, et al.
Publicado: (2020)

Multiple Medication Adherence and Related Outcomes in Community-Dwelling Older People on Chronic Polypharmacy: A Retrospective Cohort Study on Administrative Claims Data
por: Franchi, Carlotta, et al.
Publicado: (2022)

Economic Evaluations of Interventions to Optimize Medication Use in Older Adults with Polypharmacy and Multimorbidity: A Systematic Review
por: Laberge, Maude, et al.
Publicado: (2021)

Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2023)

Are multimorbidity patterns associated with fear of falling in community-dwelling older adults?
por: Canever, Jaquelini Betta, et al.
Publicado: (2022)

A Multicenter Study of Multimorbidity in Older Adult Inpatients in China
por: Zhang, L., et al.
Publicado: (2020)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Sociodemographic and lifestyle determinants of multimorbidity among community-dwelling older adults: findings from 346,760 SHARE participants
por: Ni, Wenqing, et al.
Publicado: (2023)

Frailty Status and Polypharmacy Predict All-Cause Mortality in Community Dwelling Older Adults in Europe
por: Midão, Luís, et al.
Publicado: (2021)

Development of a core outcome set for medication review in older patients with multimorbidity and polypharmacy: a study protocol
por: Beuscart, Jean-Baptiste, et al.
Publicado: (2017)

Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health
por: Sirois, Caroline, et al.
Publicado: (2019)

Sex differences in multimorbidity and polypharmacy trends: A repeated cross-sectional study of older adults in Ontario, Canada
por: Maxwell, Colleen J., et al.
Publicado: (2021)

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
por: Adam, Luise, et al.
Publicado: (2023)

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015
por: van den Akker, Marjan, et al.
Publicado: (2019)

Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
por: Patel, Preya Janubhai, et al.
Publicado: (2017)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s7f42o5567e8amg20clsfh3ldb